Stroudsburg, PA, United States of America

Patrick McVerry


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Patrick McVerry

Introduction

Patrick McVerry is a notable inventor based in Stroudsburg, PA (US). He has made significant contributions to the field of immunology, particularly through his work on the outer membrane proteins of Haemophilus influenzae type b. With a total of 3 patents, McVerry's innovations have the potential to impact vaccine development and disease prevention.

Latest Patents

One of McVerry's latest patents focuses on the outer membrane protein P1 of Haemophilus influenzae type b. This patent details methods for expressing and demonstrating the immunogenicity of recombinant P1 and its portions. It includes the nucleotide sequence of the P1 gene and the derived amino acid sequence of the P1 protein. The patent also describes methods for cloning and expressing the P1 gene, along with purification protocols for the P1 gene products. Additionally, fourteen peptides corresponding to specific sequences of the mature P1 protein are synthesized. The use of the P1 protein as an immunogen for immunization against diseases caused by Haemophilus influenzae type b is also highlighted. Furthermore, the patent discusses the use of P1 peptide-conjugates as immunizing agents to elicit anti-Haemophilus influenzae type b antibodies.

Another significant patent involves membrane proteins and peptides of Haemophilus influenzae type b. This patent discloses the nucleotide sequence of the P2 gene and the derived amino acid sequence of the P2 protein. It also outlines methods for cloning and expressing the P2 gene, as well as purification protocols. The synthesis of peptides corresponding to the N-terminal and C-terminal ends of the P2 protein is included. The P2 protein is described as a protective agent against diseases caused by Haemophilus influenzae type b, and its use as a carrier for conjugation with oligosaccharides is also discussed.

Career Highlights

Throughout his career, Patrick McVerry has worked with esteemed organizations such as Connaught Laboratories Limited and Washington University. His work has been instrumental in advancing the understanding of immunogenic proteins and their applications in vaccine development.

Collaborations

Some of McVerry's notable coworkers include Robert S Munson, Jr and Pele Chong. Their collaborative efforts have contributed to the success of his research and innovations.

Conclusion

Patrick

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…